Pike Linda J, Sadler J Evan
Washington University School of Medicine and Investigation, Howard Hughes Medical Institute, St. Louis, USA.
Mo Med. 2004 Sep-Oct;101(5):496-9.
The completion of the human genome project in 2003 ushered in the era of genomics, the systematic study of our DNA sequence. Proteomics, the study of the full complement of proteins present in a cell, is a natural extension of genomics. Together, the information obtainable through genomics and proteomics has tremendous potential to change clinical practice. The application of such information to medical diagnosis and treatment will require significant changes in the training of physicians. All students and physicians in training will need to acquire enough knowledge of the underlying science, including medical genetics, epidemiology, bioinformatics and statistics, so they will intuitively understand the technology and recognize the strengths and limitations of genomic/proteomic tests. Because genomic or proteomic testing may yield extensive information about a person's genetic makeup and disease risks, consideration will need to be given throughout the medical curriculum to the ethical issues raised by the application of this new technology to the diagnosis and treatment of patients.
2003年人类基因组计划的完成开启了基因组学时代,即对我们的DNA序列进行系统研究。蛋白质组学是对细胞中所有蛋白质的研究,是基因组学的自然延伸。通过基因组学和蛋白质组学可获得的信息共同具有改变临床实践的巨大潜力。将这些信息应用于医学诊断和治疗将需要医生培训发生重大变革。所有正在接受培训的学生和医生都需要掌握足够的基础科学知识,包括医学遗传学、流行病学、生物信息学和统计学,以便他们能够直观地理解这项技术,并认识到基因组/蛋白质组检测的优势和局限性。由于基因组或蛋白质组检测可能会产生有关一个人的基因构成和疾病风险的大量信息,因此在整个医学课程中都需要考虑将这项新技术应用于患者诊断和治疗所引发的伦理问题。